Genome wide association (GWA) predictors of anti-TNFalpha therapeutic responsiveness in pediatric inflammatory bowel disease
about
Predicting durable response or resistance to antitumor necrosis factor therapy in inflammatory bowel diseaseAssociation between Genetic Polymorphisms and Response to Anti-TNFs in Patients with Inflammatory Bowel DiseaseCurrent stage in inflammatory bowel disease: What is next?Clinical use and mechanisms of infliximab treatment on inflammatory bowel disease: a recent updateThe anatomical distribution of genetic associations.Current application of proteomics in biomarker discovery for inflammatory bowel diseaseGenetic predictors of medically refractory ulcerative colitisGenetic variation in IBD: progress, clues to pathogenesis and possible clinical utilityMeta-analysis: polymorphisms in TNF-alpha gene promoter and Crohn's disease.Clinical, serologic, and genetic factors associated with pyoderma gangrenosum and erythema nodosum in inflammatory bowel disease patientsEpidemiology, demographic characteristics and prognostic predictors of ulcerative colitis.IFNG rs1861494 polymorphism is associated with IBD disease severity and functional changes in both IFNG methylation and protein secretion.Current and future role of biomarkers in Crohn's disease risk assessment and treatment.Biologics in paediatric Crohn's disease.The chromatin-binding protein HMGN1 regulates the expression of methyl CpG-binding protein 2 (MECP2) and affects the behavior of miceReview article: the practical management of acute severe ulcerative colitis.Distinct IFNG methylation in a subset of ulcerative colitis patients based on reactivity to microbial antigens.Crucial steps in the natural history of inflammatory bowel disease.Clinical, serological and genetic predictors of inflammatory bowel disease course.Ashkenazi Jewish origin protects against formation of antibodies to infliximab and therapy failure.How does genotype influence disease phenotype in inflammatory bowel disease?Update in pediatric inflammatory bowel diseaseDysregulation of innate immunity in ulcerative colitis patients who fail anti-tumor necrosis factor therapy.NASPGHAN single-topic symposium: discovering the future of pediatric IBD care.The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease.Future therapeutic approaches for inflammatory bowel diseases.Effect of genetic polymorphisms in the folate pathway on methotrexate therapy in rheumatic diseases.Candidate mucosal and surrogate biomarkers of inflammatory bowel disease in the era of new technology.Genetic and genomic predictors of anti-TNF response.Current and future role of serogenomics in ulcerative colitis.Have genomic discoveries in inflammatory bowel disease translated into clinical progress?How does knowledge from translational research impact our clinical care of pediatric inflammatory bowel disease patients?Meta-analysis: serological markers and the risk of acute and chronic pouchitis.Ulcerative colitis: prevention of relapse.Personalizing therapy for inflammatory bowel diseases.Towards personalized care in IBD.New serological markers in pediatric patients with inflammatory bowel disease.The use of prognostic factors in inflammatory bowel diseases.Association of TNF and FcγRΙΙΙA gene polymorphisms with differential response to infliximab in a Greek cohort of Crohn's disease patients.Dashboard systems: Pharmacokinetic/pharmacodynamic mediated dose optimization for monoclonal antibodies.
P2860
Q26745721-9E4CA2E3-DFC8-48EF-A41E-B9FAA5DA44FEQ26767247-6DA16F8D-EF9C-4900-B87F-07475081FC84Q26777429-DFF487E4-2F58-450C-9B88-AAE6BAD49BF8Q26994776-F17ED409-6FAE-4ACB-9245-B2A80552F155Q27325381-359B4C51-1F1C-471E-9DEC-0ADAB9100B59Q28078755-E423E31D-8CDE-4713-863F-D2132F4E4D07Q28943368-2AF7E917-E3C4-41FE-929D-8CBFACABD766Q30251388-3755E63B-4B7B-4830-8C53-1DB60D25DC8EQ33574000-3D34D745-558B-4449-B30D-64F4AB4065A7Q33715448-2C603CF2-C0D7-447C-B934-D426A2A1DE61Q33948374-EAA9C20A-9D40-4EDE-B948-2A0E081580A0Q35082666-B443E79E-7D9B-45F1-901E-112065DDA674Q35095265-1EEA3AB9-A83A-491E-85D4-4B67DE55B427Q35579308-B7198155-2435-4305-B3CC-0A4295EC258EQ35604954-18BDF201-8185-429D-8081-FA69BBA5B154Q35883580-120267C8-3E13-4330-ACD7-FB01DDDD7FC7Q36104271-C77EC2BE-3FE7-43C9-AA3B-B994C0579000Q36144457-8FBDD733-9952-4D0A-9DF4-D32DCD806D90Q36144470-1073BDC7-C95E-4657-8FBB-744DE397C663Q36151324-3A7A8894-6C0E-458D-9500-9499ADBE3769Q37038666-52D405E2-E62E-470F-9E73-685E08F754D6Q37279540-C58A88E9-EDB2-43F8-B4FE-9266705EDD95Q37411301-C78723CF-9F5F-4E6B-804B-FA14D098CF70Q37467578-5D6460CB-7694-4A96-B4DD-37940D5261BAQ37870433-172D9125-1721-451F-B210-046312098CFBQ37870435-A21FB052-5659-4D94-8DC0-5EDA1227E634Q37946958-C0F6D282-416C-4015-95C9-F26E94246F79Q37951110-52CBA512-2B7D-4CB3-AD60-5CB2880B14FFQ37951648-4150B8B6-AC0D-472D-8D48-4A810D6DF18EQ37980742-9997B7D4-283C-4D3F-8DDA-F58C789E2B6CQ37981121-F3D529D6-8585-4E99-BCB5-DC2A5D955359Q37994130-0A8E35F8-E2D4-4569-8DCB-575AA4FC1A98Q38088288-F1033E4A-9760-4B31-B4F9-288D8EAC0841Q38103628-1EF556F2-F495-45FC-936B-1BE422858E34Q38132279-82D373CD-F8D0-4A7A-B2EB-1AC333F1EBE1Q38171924-3B1E15FD-0DC2-4337-BD83-FB28A6F20D08Q38209922-2F68C822-1518-4174-991B-B5B074B04BBBQ38254878-A971000B-6ABC-40AB-A6CB-B92160CEC878Q38356810-81E51393-B943-46D7-919D-205CCD5CD754Q38364464-42606D8A-70E4-45A3-BDB3-CE8211BED0A5
P2860
Genome wide association (GWA) predictors of anti-TNFalpha therapeutic responsiveness in pediatric inflammatory bowel disease
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Genome wide association (GWA) ...... ric inflammatory bowel disease
@ast
Genome wide association (GWA) ...... ric inflammatory bowel disease
@en
type
label
Genome wide association (GWA) ...... ric inflammatory bowel disease
@ast
Genome wide association (GWA) ...... ric inflammatory bowel disease
@en
prefLabel
Genome wide association (GWA) ...... ric inflammatory bowel disease
@ast
Genome wide association (GWA) ...... ric inflammatory bowel disease
@en
P2093
P2860
P50
P921
P356
P1476
Genome wide association (GWA) ...... ric inflammatory bowel disease
@en
P2093
Cecilia Kim
Dermot P McGovern
Joseph Glessner
Kent D Taylor
Madison Friedman
Marla C Dubinsky
Stephan R Targan
Talin Haritunians
Tanvi Dhere
P2860
P304
P356
10.1002/IBD.21174
P577
2010-08-01T00:00:00Z